Literature DB >> 15131673

Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population.

I D Ladas1, A A Rouvas, M M Moschos, E E Synodinos, D A Karagiannis, C N Koutsandrea.   

Abstract

PURPOSE: To study the prevalence, the clinical features, and the visual prognosis without treatment of polypoidal choroidal vasculopathy (PCV) in a large series of Greek patients presenting with exudative maculopathy.
METHODS: The medical records, photographs,as well as fluorescein and indocyanine green(ICG) angiograms of a series of 268 consecutive elderly white Greek patients, who were originally diagnosed as having exudative age-related macular degeneration (AMD) were reviewed retrospectively.
RESULTS: In all, 22 of the 268 (8.2%) patients initially suspected of having AMD were ultimately diagnosed with PCV. In 15 of the 22(68.2%) patients with PCV, the polypoidal lesions were located in the peripapillary area. Large soft drusen were present in only two fellow eyes of the 10 (20%) patients with unilateral PCV compared with 120 fellow eyes of the 148 (81.1%) patients with unilateral AMD. At the last examination, 11 of the 22(50%) patients with PCV and 120 of the 246(48.8%) patients with AMD presented a visual acuity of less than 6/60 in at least one eye due to scar formation in the macula.
CONCLUSIONS: PCV is not an infrequent disease in Greece. A measurable number of Greek patients with findings suggestive of exudative AMD will instead have PCV. ICG angiography is important in differentiating between these two clinical entities. In Greeks, polypoidal lesions are predominantly peripapillary and are not usually associated with macular drusen in the fellow eye. PCV and exudative AMD do not differ significantly in terms of their natural course and visual prognosis in Greek patients.

Entities:  

Mesh:

Year:  2004        PMID: 15131673     DOI: 10.1038/sj.eye.6700706

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  29 in total

1.  Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.

Authors:  Masaaki Saito; Mariko Kano; Kanako Itagaki; Shigeyuki Ise; Kimihiro Imaizumi; Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2015-09-09       Impact factor: 2.447

Review 2.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

3.  Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial.

Authors:  Won Ki Lee; Tomohiro Iida; Yuichiro Ogura; Shih-Jen Chen; Tien Yin Wong; Paul Mitchell; Gemmy Chui Ming Cheung; Zhongqi Zhang; Sérgio Leal; Tatsuro Ishibashi
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

4.  Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.

Authors:  M Saito; T Iida; M Kano; K Itagaki
Journal:  Eye (Lond)       Date:  2013-06-07       Impact factor: 3.775

5.  Characteristics of age-related macular degeneration in patients with diabetic retinopathy.

Authors:  Tadanobu Yoshikawa; Nahoko Ogata; Mitsumasa Wada; Tsuyoshi Otsuji; Kanji Takahashi
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

6.  Polypoidal choroidal vasculopathy with drusen.

Authors:  Daisuke Iwama; Akitaka Tsujikawa; Manabu Sasahara; Yasuhiko Hirami; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

7.  Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy.

Authors:  Eleftherios I Agorogiannis; Ian A Pearce; Sohraab Yadav; David G Parry; Nicholas A V Beare
Journal:  Eye (Lond)       Date:  2018-07-12       Impact factor: 3.775

8.  Evidence of a novel gene HERPUD1 in polypoidal choroidal vasculopathy.

Authors:  Enzhong Jin; Yujing Bai; Lvzhen Huang; Min Zhao; Chunfang Zhang; Mingwei Zhao; Xiaoxin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population.

Authors:  Koji Tanaka; Tomohiro Nakayama; Mitsuko Yuzawa; Zhaoxia Wang; Akiyuki Kawamura; Ryusaburou Mori; Hiroyuki Nakashizuka; Naoyuki Sato; Yoshihiro Mizutani
Journal:  Mol Vis       Date:  2011-10-22       Impact factor: 2.367

10.  SERPING1 polymorphisms in polypoidal choroidal vasculopathy.

Authors:  Meng Li; Feng Wen; Chengguo Zuo; Xiongze Zhang; Hui Chen; Shizhou Huang; Guangwei Luo
Journal:  Mol Vis       Date:  2010-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.